Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index.

Date publication

janvier 2018

Journal

Alimentary pharmacology & therapeutics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Lo B, Prosberg MV, Gluud LL, Chan W, Leong RW, van der List E, van der Have M, Sarter H, Gower-Rousseau C, Peyrin-Biroulet L, Vind I, Burisch J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28994131

Résumé

The Inflammatory Bowel Disease Disability Index (IBD-DI) has recently been developed for patients with Crohn's disease (CD) and ulcerative colitis (UC).

Mots clés

Colitis, Ulcerative, physiopathology, Crohn Disease, physiopathology, Cross-Sectional Studies, Disabled Persons, Humans, Reproducibility of Results

Référence

Aliment. Pharmacol. Ther.. 2018 Jan;47(1):6-15